AVXL

NASDAQStock

Anavex Life Sciences Corp.

$4.66+0.01 (+0.22%)

52-Week Range

$3.08
$13.41

Key Stats

Market Cap

431.9M

P/E Ratio

Dividend Yield

Beta

1.05

Volume

819.9K

Avg Volume

1.1M

Performance

1M

+18.62%

3M

+12.32%

6M

-48.82%

YTD

+26.36%

1Y

-50.69%

3Y

-50.32%

5Y

-68.62%

Price Chart

ETF Exposure

AVXL is held by 63 ETFs

ETFFund NameWeight
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
PreviousPage 2 of 2

About AVXL ETF Exposure

Anavex Life Sciences Corp. (AVXL) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 431.9M, AVXL is a widely held institutional stock. The stock currently trades at $4.66. Investors can gain exposure to AVXL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AVXL, sorted by portfolio weight.